We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Tag: atherosclerosis
MedXY News
EnglishTag

atherosclerosis

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Colchicine for Secondary Prevention After Stroke According to the Presence of Atherosclerosis: Clinical Evidence and Implications
Cardiologycardiovascular eventsstroke prevention

Colchicine for Secondary Prevention After Stroke According to the Presence of Atherosclerosis: Clinical Evidence and Implications

By MedXY|Aug 21, 2026

This review synthesizes evidence on colchicine’s efficacy in secondary stroke prevention, emphasizing the impact of concomitant atherosclerosis on outcomes from the CONVINCE trial and meta-analyses.

GLP-1 Receptor Agonists: A Breakthrough in Reducing Atherosclerosis and Cardiovascular Risk Beyond Diabetes and Obesity
Cardiologyatherosclerosis
cardiovascular events

GLP-1 Receptor Agonists: A Breakthrough in Reducing Atherosclerosis and Cardiovascular Risk Beyond Diabetes and Obesity

By MedXY|Jul 22, 2026

GLP-1 receptor agonists significantly reduce atherosclerosis progression, inflammatory biomarkers, and cardiovascular events independent of glycaemic control and obesity status, evidenced by robust preclinical and large-scale clinical data.

Non-HDL Cholesterol and Apolipoprotein B Measures and Risk of Atherosclerotic Cardiovascular Disease
Cardiologyapolipoprotein Batherosclerosis

Non-HDL Cholesterol and Apolipoprotein B Measures and Risk of Atherosclerotic Cardiovascular Disease

By MedXY|Jul 16, 2026

This study compares the predictive value of non-HDL cholesterol and apolipoprotein B for atherosclerotic cardiovascular disease risk in individuals not on lipid-lowering medication.

Blood DNA Methylation Maps Atherosclerosis Across Vascular Beds: Strong Signals, but Mostly a Record of Cumulative Risk Exposure
CardiologyatherosclerosisDNA methylation

Blood DNA Methylation Maps Atherosclerosis Across Vascular Beds: Strong Signals, but Mostly a Record of Cumulative Risk Exposure

By MedXY|Jun 19, 2026

In 2 prospective cohorts, blood DNA methylation was associated with carotid, coronary, and peripheral atherosclerosis, but most signals overlapped with smoking and cardiometabolic risk factors rather than vessel-specific biology.

Silent Plaque Ruptures in Non-Obstructive Lesions of Non-Infarct-Related Arteries: What Serial Coronary Imaging Reveals
Cardiologyacute myocardial infarctionatherosclerosis

Silent Plaque Ruptures in Non-Obstructive Lesions of Non-Infarct-Related Arteries: What Serial Coronary Imaging Reveals

By MedXY|Jun 10, 2026

In patients with acute myocardial infarction, silent plaque rupture was found in 12% of non-obstructive lesions in non-infarct-related arteries. Larger plaques, positive remodeling, and thinner fibrous caps were linked to rupture, and more

Apolipoprotein C-III Inhibition and the Atherosclerosis Paradox: Lessons from the Essence-TIMI 73b Olezarsen Study
CardiologyatherosclerosisCardiology

Apolipoprotein C-III Inhibition and the Atherosclerosis Paradox: Lessons from the Essence-TIMI 73b Olezarsen Study

By MedXY|Apr 9, 2026

The Essence-TIMI 73b trial reveals that despite a 64% reduction in triglycerides and a 72% drop in remnant cholesterol via olezarsen, non-calcified coronary plaque volume remained unchanged over 12 months.

Inhibiting Myeloid-PlexinD1: A Novel Strategy to Stabilize Atherosclerosis at High-Risk Vascular Bifurcations
Cardiologyatherosclerosishemodynamics

Inhibiting Myeloid-PlexinD1: A Novel Strategy to Stabilize Atherosclerosis at High-Risk Vascular Bifurcations

By MedXY|Mar 9, 2026

Research reveals that PlexinD1 mediates macrophage-driven inflammation in response to disturbed blood flow. By targeting this pathway, scientists have successfully attenuated plaque progression in preclinical models, paving the way for adva

ACTA2 Pathogenic Variants: Unmasking the Link Between Smooth Muscle Cell Stress and Early-Onset Atherosclerosis
Cardiologyatherosclerosis

ACTA2 Pathogenic Variants: Unmasking the Link Between Smooth Muscle Cell Stress and Early-Onset Atherosclerosis

By MedXY|Mar 3, 2026

Recent research identifies a specific molecular pathway—driven by HSF1 activation and increased cholesterol biosynthesis in smooth muscle cells—that explains why certain ACTA2 mutations predispose patients to premature atherosclerotic cardi

Angiographic Burden of Coronary Atherosclerosis: The Critical Mediator Between ASCVD Risk Factors and Cardiovascular Outcomes
CardiologyatherosclerosisCardiology

Angiographic Burden of Coronary Atherosclerosis: The Critical Mediator Between ASCVD Risk Factors and Cardiovascular Outcomes

By MedXY|Mar 2, 2026

This Mendelian randomization study reveals that coronary plaque burden significantly mediates the link between traditional risk factors and adverse events like myocardial infarction and heart failure, reinforcing the necessity of early prim

Distinct Neuroimaging Signatures: Atrial Fibrillation and Atherosclerosis Drive Divergent Vascular Brain Lesion Patterns
Cardiologyatherosclerosisatrial fibrillation

Distinct Neuroimaging Signatures: Atrial Fibrillation and Atherosclerosis Drive Divergent Vascular Brain Lesion Patterns

By MedXY|Jan 5, 2026

A large-scale comparative study of 3,508 patients reveals that atrial fibrillation and atherosclerosis produce significantly different vascular brain lesions on MRI, with AF favoring non-lacunar infarcts and periventricular white matter cha

Elevated LDL-C Increases Cardiovascular Risk in Symptomatic Patients Despite a Coronary Calcium Score of Zero
Cardiologyatherosclerosiscardiovascular risk

Elevated LDL-C Increases Cardiovascular Risk in Symptomatic Patients Despite a Coronary Calcium Score of Zero

By MedXY|Jan 3, 2026

A large-scale cohort study from the Western Denmark Heart Registry demonstrates that high LDL-C remains a significant predictor of non-calcified plaque and coronary heart disease events in patients with a CAC score of zero, particularly amo

Long-Term Silicon Exposure Fails to Predict Coronary Artery Disease Severity or Systemic Inflammation
Cardiologyatherosclerosisbiomarkers

Long-Term Silicon Exposure Fails to Predict Coronary Artery Disease Severity or Systemic Inflammation

By MedXY|Dec 24, 2025

A pilot study evaluating hair silicon as a long-term mineral marker found no significant association between silicon concentrations and coronary artery disease (CAD) severity or inflammatory markers, suggesting silicon may be metabolically

Elevated Blood Pressure in Adolescence Predicts Dose‑Dependent Coronary Atherosclerosis in Middle Age: Implications for Early Detection and Prevention
CardiologyatherosclerosisCoronary CTA

Elevated Blood Pressure in Adolescence Predicts Dose‑Dependent Coronary Atherosclerosis in Middle Age: Implications for Early Detection and Prevention

By MedXY|Dec 2, 2025

A Swedish cohort study of 10,222 men linked adolescent blood pressure to coronary atherosclerosis by CCTA ~40 years later; higher systolic BP in adolescence, even in the ‘elevated’ range, was associated with greater odds of severe (>50%)

Invisible Invaders: How Microplastics May Accelerate Atherosclerosis — and Why Men Could Be at Greater Risk
Cardiologyatherosclerosiscardiovascular risk

Invisible Invaders: How Microplastics May Accelerate Atherosclerosis — and Why Men Could Be at Greater Risk

By MedXY|Nov 25, 2025

New animal research links oral microplastic exposure to dramatic increases in arterial plaque—especially in males—by injuring endothelial cells and provoking inflammation and oxidative stress.

Targeting NEK7 with an Oral Molecular-Glue Degrader: MRT-8102 Advances an Upstream Inflammasome Strategy for Cardiovascular Inflammation
CardiologyatherosclerosisNEK7

Targeting NEK7 with an Oral Molecular-Glue Degrader: MRT-8102 Advances an Upstream Inflammasome Strategy for Cardiovascular Inflammation

By MedXY|Nov 12, 2025

Preclinical AHA 2025 data show MRT-8102, an oral NEK7-directed molecular glue degrader, selectively degrades NEK7, suppresses NLRP3 inflammasome activation and pyroptosis across species, and reduces multi-cytokine release—supporting Phase 1

Subclinical Vascular Burden Predicts 20‑Year Cognitive Decline: Arteriosclerosis and Atherosclerosis Outperform Blood Pressure and Cardiac Measures
Cardiologyatherosclerosiscognitive decline

Subclinical Vascular Burden Predicts 20‑Year Cognitive Decline: Arteriosclerosis and Atherosclerosis Outperform Blood Pressure and Cardiac Measures

By MedXY|Nov 5, 2025

In MESA, baseline subclinical arteriosclerosis and atherosclerosis scores predicted greater cognitive decline and higher odds of MCI/dementia over 20 years, independently of clinical dementia risk factors.

The Hidden Cardiovascular Risks of Anabolic Steroid Abuse in Men and Women: Insights from a Danish Study
CardiologyatherosclerosisCardiovascular Risks

The Hidden Cardiovascular Risks of Anabolic Steroid Abuse in Men and Women: Insights from a Danish Study

By MedXY|Oct 27, 2025

This study highlights the association between illicit anabolic steroid use and adverse cardiovascular outcomes in both sexes, emphasizing the need for preventive strategies in recreational sports.

Repurposing Antihypertensive Drug Trazosin to Delay Vascular Aging: A Breakthrough in Atherosclerosis Management
Cardiologyatherosclerosisautophagy

Repurposing Antihypertensive Drug Trazosin to Delay Vascular Aging: A Breakthrough in Atherosclerosis Management

By MedXY|Oct 8, 2025

New research identifies transcription factor ATF3 as a key regulator of vascular smooth muscle cell aging and reveals low-dose trazosin, a commonly used antihypertensive, as a potential therapy to delay vascular aging and atherosclerosis pr

The Hidden Vascular Assassin: How Homocysteine Independently Accelerates Atherosclerosis
Medical Newsatherosclerosiscardiovascular risk

The Hidden Vascular Assassin: How Homocysteine Independently Accelerates Atherosclerosis

By MedXY|Sep 14, 2025

Beyond cholesterol and blood pressure, homocysteine silently hardens arteries, driving cardiovascular disease progression independently—latest research reveals its biomechanical impact and prevention strategies.

The Hidden Threat in Your Mouth: How Oral Bacteria Can Trigger Heart Attacks
Dentistryatherosclerosisinflammation

The Hidden Threat in Your Mouth: How Oral Bacteria Can Trigger Heart Attacks

By MedXY|Oct 23, 2025

New research reveals that common oral bacteria, particularly Viridans streptococci, can infiltrate arterial plaques, increasing the risk of heart attacks by triggering inflammation and plaque rupture.

1 / 2
12
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities